We are live on ! Find out more
DF

DC Funds Portfolio holdings

AUM $1.49M
1-Year Est. Return 18.57%
This Fund
S&P 500
This Quarter Est. Return
-32.69%
1 Year Est. Return
-18.57%
3 Year Est. Return
-38.34%
5 Year Est. Return
-87.14%
10 Year Est. Return
AUM
$16.9M
AUM Growth
-$8.58M
Cap. Flow
-$124K
Cap. Flow %
-0.73%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
HOWL icon
Werewolf Therapeutics
HOWL
+$124K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRNS
1
Barinthus Biotherapeutics
BRNS
$22.8M
$7.13M 42.25%
642,204
HOWL icon
2
Werewolf Therapeutics
HOWL
$17.2M
$6.92M 40.97%
580,902
-8,200
-1% -$124K
TCRX icon
3
TScan Therapeutics
TCRX
$48.6M
$2.83M 16.79%
630,000

Similar funds

DC Funds's Q4 2021 Portfolio in Review

As of Q4 2021, DC Funds held 3 positions worth $16.9M, down 34% from $25.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 0%. DC Funds opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • DC Funds's biggest Q4 2021 reduction was Werewolf Therapeutics, cutting an estimated $124K.
  • DC Funds's ten largest holdings make up 100% of its $16.9M portfolio in Q4 2021.
  • DC Funds opened 0 new positions and closed 0 in Q4 2021.
  • DC Funds's portfolio value fell 34% quarter-over-quarter to $16.9M.

Based on DC Funds's 13F filing for Q4 2021, filed 11 Feb 2022.